SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers.

Collinson, P (2015) Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers. EJIFCC, 26 (3). pp. 183-189. ISSN 1650-3414
SGUL Authors: Collinson, Paul

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (978kB) | Preview
[img] Microsoft Word (.doc) Accepted Version
Available under License Creative Commons Attribution Non-commercial.

Download (185kB)
Item Type: Article
Additional Information: Copyright © 2015 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: biomarkers, cost effectiveness, evidence-based medicine, test evaluation
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cardiac (INCCCA)
Journal or Publication Title: EJIFCC
ISSN: 1650-3414
Language: eng
Dates:
DateEvent
August 2015Published
24 July 2015Published Online
PubMed ID: 27683493
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/108964

Actions (login required)

Edit Item Edit Item